TELA Bio Inc (TELA)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current TELA market cap is 110.29M. The company's latest EPS is USD -1.1847 and P/E is -2.38.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 15.05M | 17M | 16.6M | 16.09M | 18.96M |
| Operating Income | -10.18M | -12.28M | -12.41M | -11.57M | -9.37M |
| Net Income | -10.96M | -12.89M | -5.66M | -12.6M | -10.37M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 15.45M | 18.21M | 29.46M | 41.42M | 58.45M |
| Operating Income | -19.16M | -25.28M | -29.45M | -39.01M | -44.08M |
| Net Income | -30.21M | -28.79M | -33.28M | -44.3M | -46.66M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 87.32M | 78.05M | 71.84M | 60.2M | 53.02M |
| Total Liabilities | 56.77M | 59.17M | 57.45M | 57.33M | 59.29M |
| Total Equity | 30.55M | 18.88M | 14.38M | 2.87M | -6.27M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 67.92M | 86.46M | 62.54M | 67.86M | 78.05M |
| Total Liabilities | 36.96M | 37.43M | 42.45M | 53.55M | 59.17M |
| Total Equity | 30.96M | 49.03M | 20.1M | 14.31M | 18.88M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -29.81M | -40.86M | -14.38M | -25.08M | -34.06M |
| Investing | -406k | -599k | 4.7M | 4.76M | 4.64M |
| Financing | 46.25M | 46.27M | 56k | 51k | 149k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -25.52M | -24.46M | -30.43M | -40.75M | -40.86M |
| Investing | -11.98M | 9.12M | -627k | -1.87M | -599k |
| Financing | 65.53M | 44.41M | 585k | 40.85M | 46.27M |
| Market Cap | 110.29M |
| Price to Earnings Ratio | -2.38 |
| Price to Sales Ratio | 1.9 |
| Price to Cash Ratio | 2.38 |
| Price to Book Ratio | 5.88 |
| Dividend Yield | - |
| Shares Outstanding | 39.39M |
| Average Volume (1 week) | 326.56k |
| Average Volume (1 Month) | 188.93k |
| 52 Week Change | -57.19% |
| 52 Week High | 7.52 |
| 52 Week Low | 2.30 |
| Spread (Intraday) | 0.03 (1.06%) |
| Company Name | TELA Bio Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.telabio.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
